Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.750
+0.130 (4.96%)
Sep 30, 2026, 4:00 PM EDT - Market closed
Perspective Therapeutics Employees
As of December 31, 2025, Perspective Therapeutics had 166 total employees, including 163 full-time and 3 part-time employees. The number of employees increased by 26 or 18.57% compared to the previous year.
Employees
166
Change (1Y)
26
Growth (1Y)
18.57%
Revenue / Employee
$2,464
Profits / Employee
-$701,410
Market Cap
313.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 166 | 26 | 18.57% | 163 | 3 |
| Dec 31, 2024 | 140 | 21 | 17.65% | 138 | 2 |
| Dec 31, 2023 | 119 | 53 | 80.30% | 116 | 3 |
| Jun 30, 2022 | 66 | 5 | 8.20% | 66 | 0 |
| Jun 30, 2021 | 61 | 8 | 15.09% | 61 | 0 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,438 |
| InfuSystem Holdings | 473 |
| Treace Medical Concepts | 450 |
| Standard BioTools | 389 |
| AVITA Medical | 226 |
| ClearPoint Neuro | 172 |
| TriSalus Life Sciences | 102 |
CATX News
- 12 days ago - Perspective Therapeutics initiated with an Outperform at William Blair - TheFly
- 14 days ago - Perspective Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 16 days ago - Perspective Therapeutics announces trial collaboration agreement with Merck - TheFly
- 16 days ago - Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors - GlobeNewsWire
- 19 days ago - Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the 38th EORTC-NCI-AACR Symposium 2026 - GlobeNewsWire
- 6 weeks ago - BMO Capital starts Perspective at Outperform, cites pipeline opportunities - TheFly
- 6 weeks ago - Perspective Therapeutics initiated with an Outperform at BMO Capital - TheFly
- 6 weeks ago - Perspective Therapeutics price target lowered to $5 from $6 at BofA - TheFly